Author:
Cai Xiaoshu,Genchev Georgi Z.,He Ping,Lu Hui,Yu Guangjun
Abstract
Abstract
Background
Rare diseases are ailments which impose a heavy burden on individual patients and global society as a whole. The rare disease management landscape is not a smooth one—a rare disease is quite often hard to diagnose, treat, and investigate. In China, the country’s rapid economic rise and development has brought an increased focus on rare diseases. At present, there is a growing focus placed on the importance and public health priority of rare diseases and on improving awareness, definitions, and treatments.
Methods
In this work we utilized clinical data from the Shanghai HIE System to characterize the status of 33 rare diseases with effective treatment in Shanghai for the time period of 2013–2016.
Results and conclusion
First, we describe the total number of patients, year-to-year change in new patients with diagnosis in one of the target diseases and the distribution of gender and age for the top six (by patient number) diseases of the set of 33 rare diseases. Second, we describe the hospitalization burden in terms of in-hospital ratio, length of stay, and medical expenses during hospitalization. Finally, rare disease period prevalence is calculated for the rare diseases set.
Funder
National Key Clinical Specialty Discipline Construction Program of China
Science and Technology Commission of Shanghai Municipality
Shanghai Municipal Commission of Health and Family Planning
Medical Conversion Cross-Fund of Shanghai Jiao Tong University
Neil Shen’s SJTU Medical Research Fund
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献